💊 MEDICATIONS
For the pain physician, Urine Drug Testing (UDT) is not a tool for “catching” patients; it is a critical safety intervention and an objective component of risk stratification. On the board exams, UDT questions are notoriously high-yield, focusing on the...
💊 MEDICATIONS
In the pharmacological management of pain, “adjuvant” medications are those primarily indicated for non-pain conditions (such as hypertension or inflammation) that possess significant analgesic properties. Alpha-2 Adrenergic Agonists and Corticosteroids...
💊 MEDICATIONS
In the modern landscape of pain management, topical analgesics have transitioned from “ancillary” treatments to primary strategies, particularly for geriatric populations and those at high risk for systemic drug-drug interactions. The appeal of topical...
💊 MEDICATIONS
As we move toward the more advanced pain pharmacology, we encounter medications that do not merely “numb” pain or “strengthen” inhibition, but instead target the fundamental physiological changes that occur when pain becomes chronic. NMDA...
💊 MEDICATIONS
“Muscle relaxants” are frequently tested, yet the term itself is a clinical misnomer. Most of these medications do not act directly on the muscle fibers; instead, they exert their effects on the central nervous system (CNS). For the clinician, the most...
